SCHEMBL6038159

SCHEMBL6038159

O=[C]OCc1ccc2c(c1[N+](=O)[O-])OCO2

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 1/20 0.56
TXNRD3 Q86VQ6 1/20 0.56
TXNRD2 Q9NNW7 1/20 0.56
MAPT P10636 4/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
MCL1 Q07820 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
AOC3 Q16853 3/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
MTOR P42345 1/20 0.32
VCP P55072 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
NQO2 P16083 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3328445 0.79 TXNRD1 (0.66) TXNRD1TXNRD3TXNRD2MAPTMEN1
SCHEMBL5233976 0.78 TXNRD1 (0.54) TXNRD1TXNRD3TXNRD2MAPTMEN1
SCHEMBL5234315 0.78 TXNRD1 (0.64) TXNRD1TXNRD3TXNRD2MAPTMEN1
SCHEMBL1898972 0.77 TXNRD1 (0.49) TXNRD1TXNRD3TXNRD2MAPTMEN1
SCHEMBL496224 0.75 MAPT (0.51) TXNRD1TXNRD3TXNRD2MAPTMEN1
SCHEMBL11238865 0.73 TXNRD1 (0.38) TXNRD1TXNRD3TXNRD2MAPTNPC1
SCHEMBL774829 0.73 TXNRD1 (0.54) TXNRD1TXNRD3TXNRD2MAPTMEN1
SCHEMBL6046956 0.72 TXNRD1 (0.49) TXNRD1TXNRD3TXNRD2MAPTMEN1
SCHEMBL773992 0.71 TXNRD1 (0.68) TXNRD1TXNRD3TXNRD2MAPTMEN1
SCHEMBL5239589 0.71 TXNRD1 (0.68) TXNRD1TXNRD3TXNRD2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230092024-A1 Increasing Efficiency Of Photochemical Reactions On Substrates CENTRILLION TECHNOLOGIES, INC. 2023-03-23 US claimed
CN-102782580-B Pattern forming method NIPPON KOGAKU KK 2015-04-22 CN claimed
US-20230092024-A1 Increasing Efficiency Of Photochemical Reactions On Substrates CENTRILLION TECHNOLOGIES, INC. 2023-03-23 US disclosed
WO-2021117680-A1 BIOLOGICAL SUBSTANCE IMMOBILIZATION MATERIAL 国立大学法人 東京大学 2021-06-17 WO disclosed
EP-3802847-A1 INCREASING EFFICIENCY OF PHOTOCHEMICAL REACTIONS ON SUBSTRATES Centrillion Technologies, Inc. (US) 2021-04-14 EP disclosed
CN-102782580-B Pattern forming method NIPPON KOGAKU KK 2015-04-22 CN disclosed
US-20130165350-A1 SURFACE LINKERS FOR ARRAY SYNTHESIS AFFYMETRIX, INC. (US) 2013-06-27 US disclosed
US-20130078389-A1 PATTERN FORMATION METHOD NIKON CORPORATION (JP) 2013-03-28 US disclosed
US-20060160099-A1 Substrate preparation process AFFYMETRIX, INC. (US) 2006-07-20 US disclosed
US-20060008840-A1 Substrate preparation process AFFYMETRIX, INC. (US) 2006-01-12 US disclosed
US-20050181431-A1 Flow device for preparation of microarrays comprising positionally distinct polymer sequences; high throughput assay AFFYMETRIX, INC. (US) 2005-08-18 US disclosed
EP-0950112-A4 PHOTOLABILE POLYMER ARRAY SYNTHESIS METHODS AFFYMETRIX INC (US) 2004-12-15 EP disclosed
US-6706875-B1 PREPARING SOLID SUBSTRATE FOR FORMING POLYMER SEQUENCES THEREON BY PROVIDING FUNCTIONAL GROUPS ON SURFACE OF SUBSTRATE AND COUPLING MONOMERS INCLUDING LIPOPHILIC PHOSPHORAMIDITE GROUPS TO FUNCTIONAL GROUPS AFFYEMTRIX, INC. 2004-03-16 US disclosed
US-20010049108-A1 Methods for reducing non-specific binding to an oligonucleotide array MCGALL GLENN (US) 2001-12-06 US disclosed
US-6307042-B1 GENERATING NUCLEOTIDE SEQUENCES; PROVIDE SUBSTRATE WAFERS, REMOVE PROTECTED GROUPS, TRANSFER SUBSTRATE WAFERS TO COUPLING STATION, TRANSFER SUBSTRATE WAFER TO ACTIVATION STATION, ANALYZE POLYMER LAYOUTS AFFYMETRIX, INC. 2001-10-23 US disclosed
EP-1071821-A1 METHODS FOR REDUCING NON-SPECIFIC BINDING TO A NUCLEIC ACID PROBE ARRAY Affymetrix, Inc. (a California Corporation) (US) 2001-01-31 EP disclosed
WO-1999054509-A1 METHODS FOR REDUCING NON-SPECIFIC BINDING TO A NUCLEIC ACID PROBE ARRAY AFFYMETRIX, INC. (US) 1999-10-28 WO disclosed
EP-0950112-A1 PHOTOLABILE POLYMER ARRAY SYNTHESIS METHODS Affymetrix, Inc. (a California Corporation) (US) 1999-10-20 EP disclosed
US-5959098-A ACTIVATING AND COUPLING MONOMERS IN DIFFERENT SELECTED ZONES OF SUBSTRATE FORMING DIFFERENT SEQUENCES IN DIFFERENT AREAS; ACTIVATING BY DIRECTING RADIATION AT SURFACE OF SUBSTRATE WITH FUNCTIONAL GROUPS PROTECTED BY PHOTOLABILE GROUPS AFFYMETRIX, INC. (US) 1999-09-28 US disclosed
WO-1997039151-A1 PHOTOLABILE POLYMER ARRAY SYNTHESIS METHODS AFFYMETRIX, INC. (US) 1997-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230092024-A1 Increasing Efficiency Of Photochemical Reactions On Substrates TYR, PCNA, DNMT1 TXNRD1 2296/4885TXNRD3 302/4885TXNRD2 1299/4885
US-20010049108-A1 Methods for reducing non-specific binding to an oligonucleotide array DCLRE1B, CD2BP2, NT5C3B TXNRD1 1912/4885TXNRD3 717/4885TXNRD2 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.